Following the UW CFAR award in 1988, the UW Center for AIDs and STD (CAS) was formed to coordinate all academic activities for both AIDS & STD at the six UW Health Services Schools and affiliated institutions. This has let to efficient and complementary organization of clinical, training, and research activities. The UW CAS administers two NIAID Research Centers, the CFAR and the STD CRC; directs medical care for three ambulatory clinics currently serving over 1,000 patients with HIV infection, two STD/HIV clinics, serving over 20,000 patients visits per year, and several HIV/STD research clinics. Six regional and international HIV/STD training programs are directly administered or coordinated by the CAS, including 3 clinical and 3 research training programs. The CAS is also funded by USAID/Family Health International to provide assistance and conduct operational research on AIDS prevention in developing countries. At present, 90 CFAR affiliated faculty are involved in AIDS/HIV-related research. Total federal funding for CFAR- affiliated investigators total $19,000,000 for AIDS/HIV-related research, including over $9,700,000 from NIAID; and over $6,700,000 for other STD- related research. Key NIAID HIV research grants in addition to the CFAR, include the following: ACTU; Pediatric-Perinatal ACTU; AVEU; NCDVG; PAVE; PEBRA; two AIDS Research Training Grants and several R01 grants. The CFAR coordinated development of 5,800 square feet of CFAR laboratory space for AIDS research (and will develop another 3,800 sq ft); and approximately 33,500 sq ft. of renovated space for CAS-related clinics, training, and research programs, including the clinical research, biostatistical, epidemiologic and administration cores for the CFAR and the STD CRC. The CFAR and its Internal and External Review Committees have made six New Transmission and Early Infection; Epidemiology, Pathogenesis, and Prevention. This theme describes and focuses much of the AIDS work in progress at the University of Washington and its affiliated institutions, including work in animal models, clinical epidemiologic studies of sexual and perinatal transmission in developing countries, clinical studies of genital shedding of HIV, the current CFAR has been reorganized into Administration and Developmental Cores (funding up to 10 New Investigators and new program development), and the following scientific cores, oriented around the theme of the CFAR. Clinical Research (including an International Clinical Research component); Clinical Retrovirology; Molecular Retrovirology; Immunology; Biostatistics; and AIDS Registry. A Large Scale DNA Sequencing core is planed for the 07 year.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI027757-10
Application #
2667702
Study Section
Special Emphasis Panel (SRC (71))
Project Start
1988-09-30
Project End
1998-08-31
Budget Start
1998-03-01
Budget End
1998-08-31
Support Year
10
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Washington
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Pyra, Maria; Brown, Elizabeth R; Haberer, Jessica E et al. (2018) Patterns of Oral PrEP Adherence and HIV Risk Among Eastern African Women in HIV Serodiscordant Partnerships. AIDS Behav :
Jiang, Wei; Luo, Zhenwu; Martin, Lisa et al. (2018) Drug Use is Associated with Anti-CD4 IgG-mediated CD4+ T Cell Death and Poor CD4+ T Cell Recovery in Viral-suppressive HIV-infected Individuals Under Antiretroviral Therapy. Curr HIV Res 16:143-150
Edwards, Jessie K; Cole, Stephen R; Moore, Richard D et al. (2018) Sensitivity Analyses for Misclassification of Cause of Death in the Parametric G-Formula. Am J Epidemiol :
LaCourse, Sylvia M; Cranmer, Lisa M; Bekker, Adrie et al. (2018) Symptom screening for active tuberculosis in pregnant women living with HIV. Cochrane Database Syst Rev 2018:
Merlin, Jessica S; Long, Dustin; Becker, William C et al. (2018) Brief Report: The Association of Chronic Pain and Long-Term Opioid Therapy With HIV Treatment Outcomes. J Acquir Immune Defic Syndr 79:77-82
Wagner, Anjuli D; O?Malley, Gabrielle; Firdawsi, Olivia et al. (2018) Brief Report: Disclosure, Consent, Opportunity Costs, and Inaccurate Risk Assessment Deter Pediatric HIV Testing: A Mixed-Methods Study. J Acquir Immune Defic Syndr 77:393-399
Golovaty, Ilya; Sharma, Monisha; Van Heerden, Alastair et al. (2018) Cost of Integrating Noncommunicable Disease Screening Into Home-Based HIV Testing and Counseling in South Africa. J Acquir Immune Defic Syndr 78:522-526
LaCourse, Sylvia M; Cranmer, Lisa M; Njuguna, Irene N et al. (2018) Urine Tuberculosis Lipoarabinomannan Predicts Mortality in Hospitalized Human Immunodeficiency Virus-Infected Children. Clin Infect Dis 66:1798-1801
Altekruse, Sean F; Shiels, Meredith S; Modur, Sharada P et al. (2018) Cancer burden attributable to cigarette smoking among HIV-infected people in North America. AIDS 32:513-521
Torres, Thiago S; Harrison, Linda J; La Rosa, Alberto M et al. (2018) Quality of life improvement in resource-limited settings after one year of second-line antiretroviral therapy use among adult men and women. AIDS 32:583-593

Showing the most recent 10 out of 1275 publications